Who owns PHARMACYTE BIOTECH INC?
- Ticker: PMCB
- CUSIP Number: 71715x203
Tip: Access positions for across all investors
Analyze quarterly positions in Pharmacyte Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pharmacyte Biotech stock
Who bought or sold PHARMACYTE BIOTECH INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| K2 Principal Fund | 305k | $655k | 18% | Dec 2023 |
|
| Vanguard Group | 171k | $370k | 1% | Dec 2023 |
|
| Equitec Proprietary Markets | 83k | $179k | 0% | Dec 2023 |
|
| Citadel Advisors | 42k | $92k | 5% | Dec 2023 |
|
| Dimensional Fund Advisors | 29k | $63k | 0% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 23k | $50k | 0% | Dec 2023 |
|
| Bank of New York Mellon | 17k | $36k | 0% | Dec 2023 |
|
| Squarepoint Ops | 15k | $32k | 100% | Dec 2023 |
|
| Advisor Group Holdings | 1.8k | $3.8k | -11% | Dec 2023 |
|
| CWM | 954.00 | $2.0k | 0% | Mar 2024 |
|
| Aspire Private Capital | 800.00 | $1.9k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 265.00 | $0 | 170% | Dec 2023 |
|
| Covestor | 226.00 | $0 | 20% | Dec 2023 |
|
| Bank of America Corporation | 62.00 | $139.500000 | -47% | Dec 2023 |
|
| Wells Fargo & Company | 55.00 | $118.998000 | 4% | Dec 2023 |
|
| Private Wealth Management Group | 42.00 | $91.001400 | 100% | Dec 2023 |
|
| Highlander Capital Management | 14.00 | $30.000600 | 0% | Dec 2023 |
|
| Sachetta | 14.00 | $31.000200 | 100% | Dec 2023 |
|
| UBS Group | 13.00 | $29.250000 | 44% | Dec 2023 |
|
| Jpmorgan Chase & Co | 12.00 | $26.000400 | -29% | Dec 2023 |
|
Who sold out of Pharmacyte Biotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| CSS | Sep 2023 | 13k | $28k |
| Simplex Trading | Sep 2023 | 199.00 | $0 |